Obesity, bariatric surgery, and bone

Current Opinion in Rheumatology

Volumn 23, Issue 4, 2011, Pages 396-405

  Soleymani, Taraneh ^a   Tejavanija, Sirakarn ^a   Morgan, Sarah ^b,c  

^a Departments of Nutrition Sciences and Medicine   (United States)

^b The University of Alabama at Birmingham   (United States)

^c 830 Faculty Office Tower ^*  (United States)

Author keywords

bariatric surgery; metabolic bone disease; obesity; secondary hyperparathyroidism; vitamin D

Indexed keywords

CALCIUM; CITRATE CALCIUM; COLECALCIFEROL; CYANOCOBALAMIN; ERGOCALCIFEROL; ESTROGEN; GLUCOCORTICOID; LEPTIN; MAGNESIUM; MINERAL; MULTIVITAMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHORUS; VITAMIN D; ZINC;

ADIPOCYTE; ADIPOSE TISSUE; ARTHRITIS; ARTICLE; BARIATRIC SURGERY; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CALCIUM ABSORPTION; CALORIC INTAKE; CELL DIFFERENTIATION; CELL LINEAGE; CYANOCOBALAMIN DEFICIENCY; DISEASE ASSOCIATION; DUODENUM; ELECTROLYTE DISTURBANCE; FRACTURE; HEMATOPOIETIC STEM CELL; HUMAN; HYPERINSULINEMIA; IMMOBILIZATION; INSULIN RESISTANCE; JEJUNOILEAL BYPASS; KIDNEY DISEASE; LIVER FAILURE; MEDICAL PRACTICE; METABOLIC BONE DISEASE; MORBID OBESITY; NUTRITIONAL ASSESSMENT; NUTRITIONAL DEFICIENCY; OSTEOBLAST; OSTEOLYSIS; OSTEOMALACIA; OSTEOPOROSIS; PATHOPHYSIOLOGY; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RESISTANCE TRAINING; ROUX Y ANASTOMOSIS; SECONDARY HYPERPARATHYROIDISM; STOMACH BYPASS; SURGICAL TECHNIQUE; VITAMIN D DEFICIENCY; VITAMIN INTAKE;

AVITAMINOSIS; BARIATRIC SURGERY; BONE RESORPTION; HUMANS; OBESITY, MORBID; OSTEOPOROSIS;

EID: 79958823906     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e328346f832     Document Type: Article

References (35)

1. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 303:235-241.
2. Kaidar-Person O, Person B, Szomstein S, Rosenthal RJ. Nutritional deficiencies in morbidly obese patients: a new form of malnutrition? Part A: vitamins. Obes Surg 2008; 18:870-876.
3. Kaidar-Person O, Person B, Szomstein S, Rosenthal RJ. Nutritional deficiencies in morbidly obese patients: a new form of malnutrition? Part B: minerals. Obes Surg 2008; 18:1028-1034.
4. Xanthakos SA. Nutritional deficiencies in obesity and after bariatric surgery. Pediatr Clin North Am 2009; 56:1105-1121.
5. Kaidar-Person O, Rosenthal RJ. Malnutrition in morbidly obese patients: fact or fiction? Minerva Chir 2009; 64:297-302.
6. Ernst B, Thurnheer M, Schmid SM, Schultes B. Evidence for the necessity to systematically assess micronutrient status prior to bariatric surgery. Obes Surg 2009; 19:66-73.
7. Toh SY, Zarshenas N, Jorgensen J. Prevalence of nutrient deficiencies in bariatric patients. Nutrition 2009; 25:1150-1156.
8. Casagrande DS, Repetto G, Mottin CC, et al. Bone mineral density and nutritional profile in morbidly obese women. Obes Surg 2010; 20:1372-1379.
9. Strohmayer E, Via MA, Yanagisawa R. Metabolic management following bariatric surgery. Mt Sinai J Med 2010; 77:431-445.
10. Stein EM, Strain G, Sinha N, et al. Vitamin D insufficiency prior to bariatric surgery: risk factors and a pilot treatment study. Clin Endocrinol 2009; 71:176-183.
11. Signori C, Zalesin KC, Franklin B, et al. Effect of gastric bypass on vitamin D and secondary hyperparathyroidism. Obes Surg 2010; 20:949-952.
12. Williams SE, Cooper K, Richmond B, Schauer P. Perioperative management of bariatric surgery patients: focus on metabolic bone disease. Clev Clin J Med 2008; 75:333-349.
13. Hultin H, Edfeldt K, Sundbom M, Hellman P. Left-shifted relation between calcium and parathyroid hormone in obesity. J Clin Endocrinol Metab 2010; 95:3973-3981.
14. Vasconcelos RS, Viégas M, Marques TF, et al. Factors associated with secondary hyperparathyroidism in premenopausal women undergoing Roux-en-Y gastric bypass for the treatment of obesity. Arq Bras Endocrinol Metabol 2010; 54:233-238.
15. Reid IR. Relationships between fat and bone. Osteoporos Int 2008; 19:595-606. (Pubitemid 351642171)
16. Rosen CJ, Klibanski A. Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis. Am J Med 2009; 122:409-414.
17. Grey A, Bolland M, Gamble G, et al. The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreased bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab 2007; 92:1305-1310. (Pubitemid 46556402)
18. Gre AO, Fornari R, Rossi F, et al. Is obesity protective for osteoporosis? Evaluation of bone mineral density in individuals with high body mass index. Int J Clin Pract 2010; 64:817-820.
19. Gómez-Ambrosi J, Rodŕiguez A, Catalan V, Frühbeck G. The bone-adipose axis in obesity and weight loss. Obes Surg 2008; 28:1134-1143.
20. Gillsanz V, Chalfant J, Mo AO, et al. Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J Clin Endocrinol Metab 2009; 94:3387-3393.
21. Bredella MA, Torriani M, Hosseini GR, et al. Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women. Obesity 2011;19:49-53.
22. Russell M, Mendes N, Miller KK, et al. Visceral fat is a negative predictor of bone density measures in obese adolescent girls. J Clin Endocrinol Metab 2010; 95:1247-1255.
23. Bredella MA. Perspective: the bone-fat connection. Skeletal Radiol 2010; 39:729-731.
24. Cannon CP, Kumar A. Treatment of overweight and obesity: lifestyle, phar-macologic, and surgical options. Clin Cornerstone 2009; 9:55-68.
25. DeMaria EJ. Bariatric surgery for morbid obesity. N Engl J Med 2007; 356:2176-2183.
26. Yurcisin BM, Gaddor MM, DeMaria EJ. Obesity and bariatric surgery. Clin Chest Med 2009; 30:539-553.
27. Chan LN. Drug therapy-related issues in patients who received bariatric surgery (Part I). Pract Gastroenterol 2010; 85:26-32.
28. Heber D, Greenway FL, Kaplan LM, et al. Endocrine and nutritional management of the postbariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2010; 95:4823-4843.
29. Koch TR, Finelli FC. Postoperative metabolic and nutritional complications of bariatric surgery. Gastroenterol Clin North Am 2010; 39:109-124.
30. Ziegler O, Sirveaux MA, Brunaud L, et al. Medical follow up after bariatric surgery: nutritional and drug issues. General recommendations for the prevention and treatment of nutritional deficiencies. Diabetes Metab 2009; 35 (6 Pt 2):544-557.
31. Fleischer J, Stein EM, Bessler M, et al. The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. J Clin Endocrinol Metab 2008; 93:3735-3740.
32. Berarducci A, Haines K, Murr MM. Incidence of bone loss, falls, and fractures after Roux-en-Y gastric bypass for morbidly obesity. Appl Nursing Res 2009; (22):35-41.
33. E Wang A, Powell A. The effects of obesity surgery on bone metabolism: what orthopedic surgeons need to know. Am J Orthop 2009; 38:77-79.
34. Mechanick JI, Kushner RF, Sugerman HJ, et al. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical Guidelines for Clinical Practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient [published correction appears in Surg Obes Relat Dis 2010; 6:112]. Surg Obes Relat Dis 2008; 4 (Suppl 5):S109-S184.
35. Apovian CM, Cummings S, Anderson W, et al. Best practice updates for multidisciplinary care in weight loss surgery. Obesity 2009; 17:871-879.